Vericel Corp — Director's Dealing 2010

Mar 12, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2010-03-10

Reporting Person: DUNBAR GEORGE W JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-10	Common Stock	P	9000	$1.557	Acquired	12750	Indirect

Footnotes

F1: The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.56, inclusive. The reporting person undertakes to provide Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

F2: Reflects a 1-for-8 reverse stock split which became effective on February 18, 2010.

F3: These shares are held in a trust for the benefit of the reporting person's children. The reporting person and the reporting person's spouse are trustees of the trust. These shares were previously reported as direct holdings in error. The filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.